Niconovum

Niconovum is a Swedish pharmaceutical company specializing in the development of innovative nicotine replacement therapy (NRT) products. Founded in 2000 by Dr. Karl-Olov Fagerström, a globally recognized expert in tobacco research, the company focuses on creating faster-acting and more effective delivery systems for nicotine. Its primary product line, marketed under the brand name Zonnic, includes nicotine gum, pouches, and mouth sprays designed to help individuals quit smoking. Niconovum utilizes proprietary technology to enhance the absorption of nicotine through the oral mucosa, providing a more satisfying alternative to traditional cigarettes. In 2009, the company was acquired by Reynolds American, which is now a subsidiary of British American Tobacco, allowing Niconovum to leverage global distribution networks.